Klow Blend (80mg)

Shop KLOW Blend 80mg from Eternal Peptides, a trusted U.S. supplier of research-grade compounds recognized for strict quality standards and independent analytical verification. This advanced multi-peptide formulation combines GHK-Cu, TB-500, BPC-157, and KPV, bringing together four extensively studied compounds in one convenient blend. Each lot is tested for identity, purity, and consistency by respected third-party laboratories such as Janoshik and Finnrick Analytics, with Certificates of Analysis (COAs) available for every batch.

KLOW Blend is designed for laboratory investigations involving tissue remodeling, inflammatory signaling, vascular biology, and regenerative pathways. Order today for fast, discreet U.S. shipping and free USPS Priority delivery on orders above $200. For research use only.

What is KLOW Blend?

KLOW Blend is a multi-component peptide research formulation combining four established compounds:

• GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) – a naturally occurring copper-binding tripeptide first identified in human plasma and widely researched for extracellular matrix and collagen-related signaling
• TB-500 – a synthetic analogue inspired by thymosin beta-4, commonly studied for actin dynamics, cell migration, and angiogenesis pathways
• BPC-157 – a synthetic pentadecapeptide derived from a protective gastric protein sequence, investigated for cytoprotective and tissue-repair mechanisms
• KPV – a synthetic tripeptide derived from α-melanocyte-stimulating hormone (α-MSH), researched for inflammatory modulation and epithelial barrier signaling

This combination is designed to allow researchers to explore complementary mechanisms involved in structural repair, immune balance, vascular adaptation, and cellular recovery within a single experimental framework.

KLOW Blend is supplied in lyophilized powder form for optimal storage stability and reliable reconstitution in laboratory settings.

How KLOW Blend Works (Mechanistic Overview)

KLOW Blend is studied as a four-pathway formulation where each component contributes distinct but overlapping mechanisms:

• GHK-Cu supports copper-dependent enzymatic pathways and matrix remodeling signals
• TB-500 is associated with actin regulation, cell migration, and angiogenic activity
• BPC-157 is investigated for cytoprotective pathways, nitric oxide signaling, and vascular integrity
• KPV is studied for melanocortin-related anti-inflammatory signaling and epithelial support pathways

Together, these pathways are of interest in regenerative biology because they may address several phases of tissue recovery simultaneously: inflammation balance, vascular response, cellular movement, and structural remodeling.

Most evidence comes from preclinical studies including cell culture and animal models. Controlled human clinical evidence for the blend itself remains limited.

GHK-Cu: Matrix Remodeling and Copper Signaling

GHK-Cu functions as a copper-binding signaling complex with high affinity for Cu²⁺ ions. In research models, it is associated with:

• fibroblast activation
• collagen and elastin synthesis pathways
• antioxidant enzyme support
• modulation of gene expression linked to tissue repair

Some studies report more youthful expression profiles in aged fibroblast models and enhanced collagen organization in wound-healing experiments.

TB-500: Cellular Migration and Angiogenesis

TB-500 is primarily studied for its relationship to actin dynamics and cytoskeletal organization. This may influence:

• cell movement toward injury sites
• endothelial migration
• tube formation in angiogenesis assays
• tissue remodeling responses

Animal studies have explored increased capillary density and improved healing metrics in injury models.

BPC-157: Cytoprotection and Vascular Stability

BPC-157 has been studied across multiple tissue models for:

• nitric oxide pathway modulation
• vascular stability
• growth-factor signaling interactions
• gastrointestinal tissue resilience
• tendon and ligament repair responses

Some animal studies also explore systemic effects distant from administration sites, making it a subject of interest in whole-body recovery models.

KPV: Inflammatory Modulation and Barrier Support

KPV is derived from α-MSH and researched for its interaction with melanocortin pathways. Preclinical studies associate it with:

• reduced NF-κB activity
• lower pro-inflammatory cytokine signaling
• epithelial barrier integrity
• localized immune balance
• possible antimicrobial effects in selected models

This makes KPV valuable in studies of inflammation-driven tissue stress and mucosal barrier dysfunction.

Research Value of KLOW Blend

KLOW Blend is used in preclinical research to investigate:

• wound-healing and tissue remodeling pathways
• collagen organization and structural recovery
• angiogenesis and vascular adaptation
• inflammatory signaling balance
• musculoskeletal repair models
• epithelial barrier function
• age-related tissue maintenance research
• oxidative stress and cellular resilience

All findings are based on laboratory and animal studies only and should not be interpreted as human clinical outcomes.

KLOW Blend Characteristics

Name: KLOW Blend (GHK-Cu + TB-500 + BPC-157 + KPV)
Form: Blue-purple lyophilized powder in sterile 80mg vials
Purity: ≥99% per component (verified by third-party COAs)
Solubility: Soluble in sterile water, bacteriostatic water, or saline
Storage: Refrigerated or frozen depending duration and laboratory protocol

Each vial contains a total of 80mg of combined peptide material.

Handling & Storage Guidelines

Store unopened vials at 2–8°C (36–46°F) protected from light and moisture. For extended storage, freezing at -20°C is recommended.

After reconstitution:

• refrigerate short-term solutions
• aliquot into single-use portions for long-term storage
• avoid repeated freeze–thaw cycles
• clearly label concentration and preparation date

Use sterile technique and follow all institutional laboratory safety procedures.

COA / Quality Assurance

Every lot of KLOW Blend includes a batch-specific Certificate of Analysis (COA) generated through independent third-party testing. Reports commonly include:

• HPLC identity confirmation
• mass spectrometry verification
• purity analysis (typically ≥99%)
• sterility testing where applicable
• endotoxin screening
• storage recommendations
• lot traceability documentation

Testing partners may include Janoshik and Finnrick Analytics.

Legal Disclaimer

KLOW Blend is supplied strictly for laboratory research use only. It is not approved for human or veterinary use, diagnosis, treatment, or clinical administration of any kind.

Purchasers are responsible for complying with all local, state, federal, and institutional regulations regarding handling and use of research materials.

Any use outside lawful research contexts may result in regulatory consequences.

Scientific References

(References remain as listed in the original source material for academic traceability and further review.)